The product approval for Bactiguard Holding's foley catheters for infection prevention in China, has now been announced by China Food and Drug Administration (CFDA). The company noted that China Food and Drug Administration (CFDA) has announced that it grants regulatory approval for its foley catheter, Bactiguard Infection Protection Foley.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
73.8 SEK | +0.27% | +7.58% | +19.42% |
05-14 | Bactiguard Holding Ab Appoints Thomas Von Koch as the Chairman of the Board of Directors | CI |
04-25 | Transcript : Bactiguard Holding AB, Q1 2024 Earnings Call, Apr 25, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.42% | 245M | |
+9.95% | 27.41B | |
+21.48% | 2.36B | |
+13.31% | 2.27B | |
-48.88% | 2.2B | |
-30.74% | 2.03B | |
+21.11% | 1.84B | |
-15.10% | 1.7B | |
+6.58% | 1.34B | |
+16.77% | 1.24B |
- Stock Market
- Equities
- BACTI B Stock
- News Bactiguard Holding AB
- Bactiguard Holding Gets Product Approval in China for Foley Catheters